Clincosm LogoSign in Get a demo

PACMAN: Preoperative Anesthesia Automatic System:a Retrospective Cohort Study

Sponsor
Jeroen Bosch Ziekenhuis (Other)
Overall Status
Completed
CT.gov ID
NCT06148701
Collaborator
(none)
1,019
Enrollment
1
Location
8
Actual Duration (Months)
127.6
Patients Per Site Per Month

Study Details

Study Description

Brief Summary

To evaluate of PACMAN triage system is able to discern patient who may be safely screened by phone

Condition or Disease Intervention/Treatment Phase

    Detailed Description

    PACMAN triage system consists of a health questionnaire and an algorithm. Patient were called up by registered nurses and asked to answer the questionnaire. Patients answers were applied to PACMAN algorithm to determine what kind of screening patient should receive: in person or by phone.

    Study Design

    Study Type:
    Observational
    Actual Enrollment :
    1019 participants
    Observational Model:
    Cohort
    Time Perspective:
    Retrospective
    Official Title:
    The Preoperative Anesthesia automatiC systeM for triAge and screeNing (PACMAN) as a Model for Recognition of Patients Who May Screened by Phone: a Retrospective Cohort Study
    Actual Study Start Date :
    Oct 1, 2021
    Actual Primary Completion Date :
    Nov 1, 2021
    Actual Study Completion Date :
    Jun 1, 2022

    Outcome Measures

    Primary Outcome Measures

    1. Reduction of the number of in person consultations [between start inclusion and 6 months after start inclusion]

      In 2019 all patients were screened in person. Aim of the study is to evaluate whether implementation of PACMAN leads to a significant reduction of the number of in person consultations

    Secondary Outcome Measures

    1. Reliability of PACMAN [between start inclusion and 6 months after start inclusion]

      Reliability of the triage procedure was evaluated by verifying the PACMAN outcome (PhC vs in-PC) against the assigned ASA-PS classification. Patients scheduled for a PhC were considered to be accurately triaged if classified ASA-PS I-II or III with stable comorbidities. Patients scheduled for an in-PC were considered to be accurately triaged if classified ASA-PS III with unstable comorbidities or IV.

    2. Patients outcome [between start inclusion and 6 months after start inclusion]

      To measure the impact of PACMAN on patient outcomes we evaluated the occurrence of perioperative unanticipated adverse events (UAE). An anaesthesia-related UAE was defined as an event causing mortality or morbidity, occurring during the perioperative period or up to seven days after surgery and requiring special medical treatment or prolongation of hospitalisation beyond the expected length of stay. Data concerning perioperative UAE were collected by reviewing the EMR of patients who had undergone surgery.

    3. Cost-effectiveness [between start inclusion and 6 months after start inclusion]

      we examined cost-effectiveness and efficiency by determining the time taken by screening staff for a single PhC or in-PC and the average number of patients screened before and after implementation of PACMAN along with related staff costs.

    Eligibility Criteria

    Criteria

    Ages Eligible for Study:
    18 Years and Older
    Sexes Eligible for Study:
    All
    Accepts Healthy Volunteers:
    No
    Inclusion Criteria:

    • 18 years old, scheduled for elective clinical interventions under procedural sedation and all types of elective medium or low risk surgery with anaesthetic guidance, as defined by the European Society of Anaesthesia (ESA) guidelines.

    Exclusion Criteria:
    • <18 years. Patients scheduled for emergency and high-risk surgery were excluded as the policy of our department dictates that these patients must always be seen in person, according to ESA guidelines.

    Contacts and Locations

    Locations

    Site City State Country Postal Code
    1 Jeroen Bosch Ziekenhuis 's-Hertogenbosch Brabant Netherlands 5200 ME

    Sponsors and Collaborators

    • Jeroen Bosch Ziekenhuis

    Investigators

    • Principal Investigator: Barbe Pieters, Dr.PhD, Jeroen Bosch Hospital, 's Hertogenbosch The Netherlands

    Study Documents (Full-Text)

    None provided.

    More Information

    Publications

    None provided.
    Responsible Party:
    Jeroen Bosch Ziekenhuis
    ClinicalTrials.gov Identifier:
    NCT06148701
    Other Study ID Numbers:
    • 2021.08.06.01
    First Posted:
    Nov 28, 2023
    Last Update Posted:
    Nov 28, 2023
    Last Verified:
    Nov 1, 2023
    Individual Participant Data (IPD) Sharing Statement:
    No
    Plan to Share IPD:
    No
    Studies a U.S. FDA-regulated Drug Product:
    No
    Studies a U.S. FDA-regulated Device Product:
    No
    Keywords provided by Jeroen Bosch Ziekenhuis
    Anaesthetists / Health Care Surveys / Preoperative Care / Triage

    Study Results

    No Results Posted as of Nov 28, 2023